Brind.

Longeveron Inc. licensed stem cell technology from the University of Miami, and Joshua Hare joined the company as CSO.

1 report, 1 independent Updated Jul 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Longeveron Inc. licensed stem cell technology from the University of Miami, and Joshua Hare joined the company as CSO.

Who's involved

What this event is mainly about
University of MiamiJoshua M Hare

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireLongeveron® Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease Joshua Hare Longeveron has licensed issued US Patent 12,168,028 B2, entitl